-
MLKL Polymerization Drives Lysosomal Permeabilization in Nec
2026-05-30
Recent research establishes that MLKL polymerization directly induces lysosomal membrane permeabilization (LMP), which precedes plasma membrane rupture and drives necroptotic cell death through cathepsin B release. This mechanistic insight advances our understanding of necroptosis and highlights new experimental opportunities for dissecting regulated cell death pathways.
-
Protease Inhibitor Cocktail (EDTA-Free, 100X in DMSO): Techn
2026-05-29
The Protease Inhibitor Cocktail (EDTA-Free, 100X in DMSO) is designed to prevent proteolytic degradation during protein extraction and sample preparation, especially in workflows where EDTA is contraindicated. It is best applied in phosphorylation-sensitive assays, Western blotting, and co-immunoprecipitation protocols. This product is not suitable for workflows that require metalloprotease inhibition via EDTA.
-
Anti-ROR1 Antibody (Zilovertamab): Mechanism, Evidence & Pro
2026-05-29
Anti-ROR1 Antibody (Zilovertamab) is a humanized monoclonal antibody that blocks Wnt5a-induced ROR1 signaling, showing validated anti-tumor activity. Produced by APExBIO, it demonstrates high purity and specificity for cancer and liver injury models. This article synthesizes mechanistic evidence, benchmarks, and optimized assay protocols for translational research.
-
JC-1 Mitochondrial Membrane Potential Assay Kit: Precision Δ
2026-05-28
The JC-1 Mitochondrial Membrane Potential Assay Kit enables sensitive, ratiometric assessment of mitochondrial membrane potential in live and isolated mitochondria. This mitochondrial membrane potential assay is validated for apoptosis assays and mitochondrial function analysis in preclinical research. Its robust design, including positive controls and stable reagents, supports reproducible detection of early apoptosis and mitochondrial dysfunction.
-
Ziprasidone HCl: Protocols and Innovations for Translational
2026-05-28
Ziprasidone Hydrochloride (Ziprasidone HCl) is redefining experimental oncology and neuroscience by bridging dopaminergic signaling research with antitumor GOT1 inhibition. This guide delivers protocol-ready parameters, troubleshooting strategies, and cutting-edge permeability enhancements that set APExBIO’s product apart for dual-domain research.
-
Astrocyte Heterogeneity Atlas in Mouse and Marmoset: A Multi
2026-05-27
Schroeder et al. present a comprehensive transcriptomic atlas revealing dynamic regional and developmental heterogeneity of astrocytes in the mouse and marmoset brain. Their integrative approach uncovers previously unappreciated molecular and morphological diversity, shaping future research into brain development and glial function.
-
Hexetidine (NSC-17764): Synergy, Strategy, and Translational
2026-05-27
Explore how Hexetidine (NSC-17764) is redefining oral infection research through mechanistic insight, assay optimization, and a translational lens. This article distills evidence-backed protocols, examines synergistic mechanisms with copper, and delivers strategic guidance for researchers aiming to bridge in vitro discovery with clinical relevance.
-
Adipose ANGPTL4 Controls Triglyceride Partitioning in Mice
2026-05-26
This study demonstrates that adipocyte-derived ANGPTL4 is a key regulator of plasma triglyceride partitioning and adipose lipoprotein lipase (LPL) activity in mice. The findings reveal that while ANGPTL4 deficiency in adipocytes initially enhances triglyceride clearance and improves metabolic parameters during high-fat feeding, these benefits diminish with chronic exposure, highlighting the context-dependent role of ANGPTL4 in metabolic regulation.
-
TL1A Regulates Blood–Retinal Barrier Integrity in Diabetic R
2026-05-26
This study identifies TL1A as a critical regulator of blood–retinal barrier (BRB) stability in diabetic retinopathy, acting via modulation of the SHP-1–Src–VE-cadherin pathway. The findings offer mechanistic insight into the molecular drivers of BRB breakdown and suggest new avenues for therapeutic intervention in diabetic macular edema.
-
Polybrene (Hexadimethrine Bromide): Precision Gene Delivery
2026-05-25
Polybrene (Hexadimethrine Bromide) 10 mg/mL unlocks robust viral gene delivery and DNA transfection even in resistant cell types. This guide details experimental workflows, troubleshooting strategies, and protocol optimizations that maximize efficiency and data quality, positioning APExBIO’s formulation at the forefront of translational research.
-
2-D08: Redefining Sumoylation Inhibition for Translational I
2026-05-25
This thought-leadership article explores how 2-D08 (2’,3’,4’-trihydroxyflavone), a selective small molecule sumoylation inhibitor from APExBIO, is poised to revolutionize translational research into posttranslational modifications. By connecting recent breakthroughs in sumoylation-dependent mitophagy and the SENP2/HSPA8/FUNDC1 axis in bronchopulmonary dysplasia (BPD) models, the article offers mechanistic insight, experimental guidance, and strategic vision for researchers targeting dynamic regulatory networks in cancer and beyond.
-
Protease Inhibitor Cocktail (EDTA-Free): New Frontiers in Pl
2026-05-24
Explore how the Protease Inhibitor Cocktail (EDTA-Free, 100X in DMSO) advances plant cell protein stability by integrating insights from RNA modifications and antiviral defense. Gain a unique perspective on optimizing protein preservation for cutting-edge plant molecular research.
-
Bestatin Hydrochloride: Applied Protocols in Angiogenesis Re
2026-05-23
Bestatin hydrochloride (Ubenimex) empowers researchers to dissect aminopeptidase-driven pathways in cancer and neurobiology, streamlining studies on angiogenesis inhibition and tumor progression. This guide translates cutting-edge findings into practical protocols and troubleshooting strategies using APExBIO’s trusted reagent.
-
Targeted mRNA Nanoparticles Restore BBB After Ischemic Strok
2026-05-22
This study demonstrates that lipid nanoparticles delivering mIL-10 mRNA can selectively target microglia in ischemic brain tissue, triggering anti-inflammatory polarization and restoring blood–brain barrier integrity post-stroke. The findings offer a promising mRNA-based therapeutic platform to address neuroinflammation and secondary injury in stroke models.
-
Protease Inhibitor Cocktail: EDTA-Free Precision in Protein
2026-05-22
The Protease Inhibitor Cocktail (EDTA-Free, 100X in DMSO) empowers researchers to achieve uncompromised protein stability in cell and tissue extractions, even during demanding OXPHOS and kinase assay workflows. This guide details protocol enhancements, advanced troubleshooting, and key insights from dual-genome OXPHOS disruption studies, positioning APExBIO’s solution as the gold standard for high-fidelity proteomics.